Price Targets For Camurus

Stockholm Stock Exchange

Camurus

+38.00% (201.00)

JefferiesDNB CarnegiePareto SecuritiesNordea MarketsSEBDNB MarketsDNBBryan GarnierCarnegieHandelsbanken Capital MarketsJefferies InternationalHandelsbanken

Latest Target

+38.00%

730.00 SEK

Jefferies

Dec -25

730.00 SEK

All Price Targets For Camurus

Jefferies

Dec -25

Target: 730.00 SEKPrice: 529.00 SEK

+38.00%

DNB Carnegie

Nov -25

Target: 800.00 SEKPrice: 529.00 SEK

+51.23%

Pareto Securities

Oct -24

Target: 757.00 SEKPrice: 529.00 SEK

+43.10%

Nordea Markets

Oct -24

Target: 773.00 SEKPrice: 529.00 SEK

+46.12%

SEB

Jul -24

Target: 850.00 SEKPrice: 529.00 SEK

+60.68%

DNB Markets

Jul -24

Target: 750.00 SEKPrice: 529.00 SEK

+41.78%

DNB

Jul -24

Target: 750.00 SEKPrice: 529.00 SEK

+41.78%

Bryan Garnier

Jul -24

Target: 770.00 SEKPrice: 529.00 SEK

+45.56%

Carnegie

Jul -24

Target: 675.00 SEKPrice: 529.00 SEK

+27.60%

Handelsbanken Capital Markets

Jan -24

Target: 480.00 SEKPrice: 529.00 SEK

-9.26%

Jefferies International

Jan -24

Target: 690.00 SEKPrice: 529.00 SEK

+30.43%

Handelsbanken

Dec -21

Target: 235.00 SEKPrice: 529.00 SEK

-55.58%

About The Company

Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases.
Wikipedia